The Truth Is Out There

User Tools

Site Tools


Nicotine: Medication or Scourge?

Book Section 1)

The majority of people in most cultures uses psychoactive drugs.

In our society only three such substances are legal and freely available: caffeine, alcohol, and nicotine. One of these, nicotine, is an endangered species as the laws against its use multiply in the United States.

Almost everyone knows that smoking is hazardous to your health. It appears that nicotine is destined to become another illicit controlled substance. The disease-producing potential of smoking was first officially recognized by the Surgeon General and is now acknowledged to some extent even by smokers. In that first report, there are hints of the value of nicotine and I alluded to these in an early article. In this essay I want to point out some of the possible benefits of this drug.

References (115)

  1. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington, DC: US Department of Health, Education and Welfare, Public Health Service; 1964. DHEW Publication No. PHS 1103.
  2. Jarvik ME. The role of nicotine in the smoking habit. In: Hunt WA, ed. Learning Mechanisms in Smoking. Chicago: Aldine; 1970:155–190.
  3. Jarvik ME, Cullen JW, Gritz ER, Vogt TM, West LJ, eds. Research on Smoking Behavior. National Institute on Drug Abuse Research Monograph 17. Washington, DC: US Government Printing Office; December 1977.
  4. US Department of Health and Human Services. US Surgeon General’s Report on the Health Consequences of Smoking. Nicotine Addiction. Washington, DC: US Government Printing Office; 1988.
  5. Jaffe J. Tobacco smoking and nicotine dependence. In: Wonnacott S, Russell MAH, Stolerman IP, eds. Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects. Oxford: Oxford University Press; 1990.
  6. Warburton DM. Is nicotine use an addiction? Bull Br Psychol Soc. 1989;4:166–170.
  7. Goodman A, Rail TW, Nies AS, Taylor P, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 7th ed. New York: Pergamon Press; 1990.
  8. Stewart GG. A history of the medicinal use of tobacco 1492–1860. Med Hist. 1967;11:228–268.
  9. Larson PS, Haag HB, Silvette H. Tobacco: Experimental and Clinical Studies. Baltimore, Md: Williams & Wilkins; 1961. Suppl 1,1968; Suppl 2, 1971;Suppl 3, 1975.
  10. US Department of Health and Human Services. US Surgeon General’s Report on the Health Consequences of Smoking. Reducing the Health Consequences of Smoking: 25 Years of Progress. Washington, DC: US Government Printing Office; 1989.
  11. Russell MAH. Nicotine intake and its control over smoking. In: S Wonnacott, MAH Russell, IP Stolerman, eds. Nicotine Psychopharmacology: Moleculary Cellular, and Behavioural Aspects. Oxford: Oxford University Press; 1990:374–418.
  12. Wilbert J. Tobacco and Shamanism in South America. New Haven; Conn: Yale University Press, 1987.
  13. Goldfarb TL, Gritz ER, Jarvik ME, Stolerman IP. Reactions to cigarettes as a function of nicotine and “tar.” Clin Pharmacol Ther. 1976;196:767–772.
  14. Jones RT, Farrell TR, Herning RI. Tobacco smoking and nicotine tolerance. In: Krasnegor NA, ed.
    Self-Administration of Abused Substances: Methods for Study. NIDA Research Monograph 20. Washington, DC: US Department of Health, Education and Welfare; 1978.
  15. Henningfield JE, Goldberg SR. Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol Biochem Behav. 1983;19: 989–992. CrossRef
  16. West RJ. Nicotine: A dependence producing substance. In: Pomerleau, of Pomerleau, cs eds. Nicotine Replacement: A Critical Evaluation. New York: Alan R Liss; 1988:237–259.
  17. Rose JE, Hickman CS. Citric acid aerosol as a potential smoking cessation aid. Chest. 1987.
  18. Russell MA. Subjective and behavioural effects of nicotine in humans: Some sources of individual variation. Prog Brain Res. 1989;79:289–302. CrossRef
  19. Beckett AH, Gorrod JW, Jenner P. The effect of smoking on nicotine metabolism in vivo in Man. J Pharma Pharmacol. 1971;23 (suppl):625–627.
  20. Lewin L. Phantastica: Narcotic and Stimulating drugs—Their Use and Abuse. New York: EP Dutton; 1923.
  21. Siegel RK. Intoxication: Life in Pursuit of Artificial Paradise. New York: EP Dutton, 1989.
  22. Goldberg SR, Henningfield JE. Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of IV drug injection. Pharmacol Biochem Behav. 1988;30:227–234. CrossRef
  23. Grenhoff J, Aston-Jones G, Svensson TH. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand. 1986;128:351–358. CrossRef
  24. Imperato A, Mulas A, Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol. 1986;132:337–338. CrossRef
  25. Rowell PP, Carr LA, Garner AC. Stimulation of [3H] dopamine release by nicotine in rat nucleus accumbens. J Neurochem. 1987;49: 1449–1454. CrossRef
  26. Blozovski D, Dumery V. Development of amygdaloid cholinergic mediation of passive avoidance learning in the rat. II. Nicotinic mechanisms. Exp Brain Res. 1987;67:70–76. CrossRef
  27. Pert A, Clarke PBS. Nicotinic modulation of dopaminergic neurotransmission: functional implications. In: Martin WR, Van Loon GR, Iwamoto ET, Davis, L, eds. Tobacco Smoking and Nicotine: Advances in Behavioral Biology. New York: Plenum Press; 1987;31:169–189.
  28. Reavill C, Stolerman IP. Locomotor activity in rats after intracerebral administration of nicotine. J Psychopharm. 1988. 2:99:273–278.
  29. Grunberg NE, Bowen DJ, Morse DE. Effects of nicotine on body weight and food consumption in rats. Psychopharmacology (Berl). 1984;83:93–98. CrossRef
  30. Rodin J, Salovey P. Health psychology. Ann Rev Psych. 1989;40:533–594. CrossRef
  31. Winders SE, Grunberg NE. Effects of nicotine on body weight, food consumption and body composition in male rats. Life Sci. 1990; 46:1523–1530. CrossRef
  32. Yoshida T, Yoshioka K, Hiraoka N, Kondo M. Effect of nicotine on norepinephrine turnover and thermogenesis in brown adipose tissue and metabolic rate in MSG obese mice. J Nutr Sci Vitaminol. 1990;36:123–130. CrossRef
  33. Wellman PJ, Marmon MM, Reich S, Ruddle J. Effects of nicotine on body weight, food intake, and brown adipose tissue thermogenesis. Pharmacol Biochem Behav. 1986;246:1605–1609. CrossRef
  34. Ashton H, Millman JE, Telford R, Thompson JW. The effect of caffeine, nitrazepam, and cigarette smoking on the contingent negative variation in man. Electroencephalogr Clin Neurophysiol. 1974;37:57–71.
  35. Rose JE, Ananda S, Jarvik ME. Cigarette smoking during anxiety-provoking and monotonous tasks. Addict Behav. 1983;8:353–359. CrossRef
  36. Gilbert DG, Welser R. Emotion, anxiety and smoking. In: Ney T, Gale A, eds. Smoking and Human Behavior. New York: John Wiley & Sons; 1989:171–196.
  37. Pomerleau OF. Nicotine as a psychoactive drug: anxiety and pain reduction. Psychophar-macol Bull. 1986;22:863–883.
  38. Ikard FF, Green DE, Horn D. A scale to differentiate between types of smoking as related to the management of affect. Int J Addict. 1969;4:649–659.
  39. McKennell AC. Smoking motivation factors. Br J Soc Clin Psychol. 1970;9:8–22. CrossRef
  40. Ikard FF, Tomkins S. The experience of affect as a determinant of smoking behavior: a series of validity studies. J Abnorm Psychol. 1973;81:172–181. CrossRef
  41. Leventhal H, Avis N. Pleasure, addiction, and habit: factors in verbal report or factors in smoking behavior? J Abnorm Psychol. 1976; 85:478–488. CrossRef
  42. Gorsuch RL, Butler MC. Initial drug abuse: a review of predisposing social psychological factors. Psychol Bull. 1976;63:120–137. CrossRef
  43. Kandel D, Faust R. Sequence and stages in patterns of adolescent drug use. Arch Gen Psychol. 1975;32:923–932.
  44. Botvin GJ, Wills T. Personal and social skills training: cognitive-behavioral approaches to substance abuse prevention. In: Bell CS, Battjes R, eds. Prevention Research: Deter-ring Drug Abuse Among Young Children and Adolescents. NIDA Research Monograph No. 63. Washington DC: US Government Printing Office; 1985:8–49.
  45. Eysenck HJ. Personality and the maintenance of the smoking habit. In: Dunn WL, ed. Smoking Behaviour: Motives and Incentives. Washington, DC: Winston, 1973:113–146.
  46. Kozlowski LT. Psychosocial influences on cigarette smoking. In: Smoking and Health: A Report of the Surgeon General. Washington, DC: US Department of Health, Education and Welfare; 1979. US DHEW publication PHS 79–50066.
  47. Lerner JV, Vicary JR. Difficult temperament and drug use: analyses from the New York longitudinal study. J Drug Ed. 1984;14.1–7. CrossRef
  48. Cherry N, Kiernan KE. Personality scores and smoking behaviour: a longitudinal study. Br J Prevent Soc Med. 1976;30:123–131.
  49. Seltzer CC, Oechsli FW. Psychosocial characteristics of adolescent smokers before they started smoking: evidence of self-selection. J Chronic Dis. 1985;38:17–26. CrossRef
  50. Nesbitt PD. Smoking, physiological arousal and emotional response. J Pers Soc Psychol. 1973;25:137–145. CrossRef
  51. Schacter S. Nesbitt’s paradox. In: Dunn W, ed. Smoking Behaviour: Motives and Incentives. Washington, DC: Winston, 1973:147–156.
  52. Shiftman S, Jarvik ME. Cigarette smoking, physiological arousal, and emotional response: Nesbitt’s paradox re-examined. Addict Behav. 1984;9:95–98. CrossRef
  53. Schachter S. Pharmacological and psychological determinants of smoking. Ann Intern Med. 1978;88:104–14.
  54. Epstein L, Collins F. The measurement of situational influences of smoking. Addict Behav. 1977;2:47–54. CrossRef
  55. Schachter S, Kozlowski LT, Silverstein B. Effects of urinary pH on cigarette smoking. J Exp Psychol. 1977;106:13–19.
  56. Epstein LH, Jennings JR. Smoking, stress, cardiovascular reactivity, and coronary heart disease. In: Matthews KA, Weiss SM, Detre T, et al, eds. Handbook of Stress, Reactivity and Car¬diovascular Disease. New York: John Wiley & Sons, 1986:268–292.
  57. Schneider NG, Jarvik ME. Time course of withdrawal symptoms as a function of nicotine replacement. Psychopharmacology (Berl). 1984; 82:143–144. CrossRef
  58. Jarvik ME, Hatsukami DK. Tobacco dependence. In: Ney T, Gale A, eds. Smoking and Human Behavior. Chichester, England: John Wiley & Sons; 1989:57–67.
  59. Schachter S. Emotion, Obesity and Crime. New York: Academic Press; 1971.
  60. Morley JE, Levine AS, Rowland NE. Stress induced eating. Life Sci. 1983;32:2169–2182. CrossRef
  61. Shiftman S, Jarvik ME. Cigarette smoking, physiological arousal, and emotional response: Nesbitt’s paradox re-examined. Addict Behav. 1984;9:95–98. CrossRef
  62. Stolerman IP, Bunker P, Jarvik ME. Nicotine tolerance in rats: Role of dose and dose interval. Psychopharmacology (Berl). 1974;34:317–324. CrossRef
  63. Shiffman S. A cluster-analytic classification of smoking relapse episodes. Addict Behav. 1986;11:295–307. CrossRef
  64. Warburton DM, Walters AC. Attentional processing. In: Ney T, Gale A, eds. Smoking and Human Behavior. New York: John Wiley & Sons; 1989.
  65. Myrsten AL, Andersson K. Effects of cigarette smoking on human performance. In: Thornton RE, ed. Smoking Behaviour: Physiologiealand Psychological Influences. Edinburgh: Churchill Livingstone; 1978:156–167.
  66. Snyder FR, Henningfield JE. Effects of nicotine administration following 12 hours of tobacco deprivation: assessment on computerized performance tasks. Psychopharmacology (Berl). 1989;97:17–22. CrossRef
  67. Wesnes K, Warburton, DM. Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology (Berl). 1984;82:147–150. CrossRef
  68. Wesnes K, Warburton DM. The effects of cigarette smoking and nicotine tablets upon human attention. In: Thornton RE, ed. Smoking Behaviour: Physiological and Psychological Influences. New York: Churchill Livingstone; 1978:131–147.
  69. Cotten DJ, Thomas JR, Stewart D. Immediate effects of cigarette smoking on simple reaction time of college male smokers. Percept Mot Skills. 1971;33:336. CrossRef
  70. Morgan SF, Pickens RW. Reaction time performance as a function of cigarette smoking procedure. Psychopharmacology (Berl). 1982; 77(4):383–386. CrossRef
  71. Tong JE, Leigh G, Campbell J, Smith D. Tobacco smoking, personality and sex factors in auditory vigilance performance. Br J Psychol. 1977;68:365–370. CrossRef
  72. Snyder FR, Nemeth-Coslett R, Shanet LP, Henningfield JE. Cognitive, subjective and physiological effects of nicotine in nonsmokers. Pharmacol Biochem Behav. 27:592; 1987. CrossRef
  73. Snyder FR, Henningfield JE. Effects of nicotine administration following 12 h of tobacco deprivation: assessment on computerized performance tasks. Psychopharmacology (Berl). 1989;97:17–22. CrossRef
  74. Heishman SJ, Snyder FR, Henningfield JE. Effect of repeated nicotine administration in non-smokers. In: Harris LS, ed. Problems of Drug Dependence. NIDA Research Monograph. 1991;105:314–315.
  75. Snyder FR, Jewel JD. Nicotine administration in non-smokers. In Harris LS, ed. Problems of Drug Dependence. Nida Research Monograph. In press.
  76. Henningfield JE. Dose-related actions of nicotine on behavior and physiology: review and implications for replacement therapy for nicotine dependence. J Subst Abuse. 1989;1:301–317.
  77. Hindmarch I, Kerr JS, Sherwood N. Effects of nicotine gum on psychomotor performance in smokers and non-smokers. Psychopharmacology (Berl). 1990;100(4):535–541. CrossRef
  78. Weiss B, Laties VG. Enhancement of human performance by caffeine and the amphetamines. Pharmacol Rev. 1962;14:1–36.
  79. Aigner TG, Mitchell SJ, Aggleton JP, et al. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenicacid lesions of the nucleus basalis of Meynert. Psychopharmacology (Berl). 1987;92(3):292–300. CrossRef
  80. Sternberg DE, Jarvik ME. Memory functions in depression. Arch Gen Psychiatry. 1976; 33:219–224.
  81. Houston JP, Schneider NG, Jarvik ME. Effects of smoking on free recall and organization. Am J Psychiatry. 1978;135:220–222.
  82. Frankenhaeuser M, Myrsten AL, Post B, Johansson G. Behavioral and physiological effects of cigarette smoking in a monotonous situation. Psychopharmacology (Berl). 1971; 22:1–7. CrossRef
  83. Williams DG. Effects of cigarette smoking on immediate memory and performance in different kinds of smoker. Br J Psychol. 1980;71: 83–90. CrossRef
  84. West RJ, Jarvis M J. Effects of nicotine on finger tapping rate in non-smokers. Pharmacol Biochem Behav. 1986;25(4):727–731. CrossRef
  85. Palmen E. Ueber die einwirkung des tabkrauchesn auf die doerperliche leistungsf aehigkeit. Skaninavisches Archiv fuer Physiologic 1911;24:187–196.
  86. Johnson OJ. Effects of smoking on mental and motor efficiency. Psychol Clin. 1918;12:132–140,230–235.
  87. Hull CL. The influence of tobacco smoking on mental and motor efficiency. Psychol Monogr. 1924;33(150):7–16.
  88. Elrod K, Buccafusco JJ, Jackson WJ. Nicotine enhances delayed matching-to-sample performance by primates. Life Sci. 1988;43(3): 277–287. CrossRef
  89. Clarke PBS, Fu DS, Jakubovic A, Fibiger HC. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther. 1988;246:701–708.
  90. Levin ED, Castonguay M, Ellison GD. Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. Behav Neural Biol. 1987;48(2):206–212. CrossRef
  91. Levin ED, Ellison GD, Salem C, Jarvik M, Gritz E. Behavioral effects of acute hexamethonium in rats chronically intoxicated with nicotine. Physiol Behav. 1988;44:355–359. CrossRef
  92. Mundy WR, Iwamoto ET. Actions of nicotine on the acquisition of an autoshaped lever-touch response in rats. Psychopharmacology (Berl). 1988;94:267–274. CrossRef
  93. Levin ED, Lee C, Rose JE, et al. Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. Behav Neural Biol. 1990;53:269–76. CrossRef
  94. Reavill C. Action of nicotine on dopamine pathways and implications for Parkinson’s disease. In: Wonnacott S, Russell M AH, Stolerman IP, eds. Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects. Oxford: Oxford University Press, 1990:307–310.
  95. Moll H. The treatment of post encephalitic parkinsonism by nicotine. Br Med J. 1926;1:1079–1081. CrossRef
  96. Kahn HA. The Dorn study of smoking and mortality among US veterans: report on eight and one half years of observation. In: Haenzel W, ed. Epidemiological Approaches to the Study of Chronic Diseases. National Cancer Institute Monograph. Bethesda, Md: US Department of Health, Education and Welfare; 1966.
  97. Kessler II, Diamond EL. Epidemiologic studies of Parkinson’s disease. Smoking and Parkinson’s disease: a survey and explanatory hypothesis. Am J Epidemiol. 1971;94:16–25.
  98. Janson AM, Fuxe K, Sundstrom E, Agnati LF, Goldstein M. Chronic nicotine treatment partly protects against the l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. Acta Physiol Scand. 1988;132:589–591. CrossRef
  99. Devor EJ, Isenberg KE. Nicotine and Tourette’s syndrome. Lancet. 1989;2:1046. CrossRef
  100. Sanberg PR, McConville BJ, Fogelson HM, et al. Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome. Biomed Pharmacother. 198;43(1):19–23.
  101. Lashner BA, Hanauer SB, Silverstein MD. Testing nicotine gum for ulcerative colitis patients: experience with single-patient trials. Dig Dis Sci. 1990;35:827–832. CrossRef
  102. Srivastava ED, Hallett MB, Rhodes J. Effect of nicotine and cotinine on the production of oxygen free radicals by neutrophils in smokers and non-smokers. Hum Toxicol. 1989;8(6): 461–463. CrossRef
  103. Hickey RJ. Nicotine and ulcerative colitis. Gut. 1989;30(3):416–418. CrossRef
  104. Sahakian B, Jones G, Levy R, Gray J, Warburton D. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry. 1989;154:797–800. CrossRef
  105. Newhouse PA, Sunderland T, Tariot PN, et al. Intravenous nicotine in Alzheimer’s disease: a pilot study. Psychopharmacology (Berl). 1988; 95(2):171–175. CrossRef
  106. Barclay L, Kheyfets S. Tobacco use in Alzheimer’s disease. Prog Clin Biol Res. 1989;317:189–194.
  107. Gothe B, Strohl KP, Levin S, Cherniack NS. Nicotine: a different approach to treatment of obstructive sleep apnea. Chest. 1985;87:11–17. CrossRef
  108. Hughes JR, Higgins ST, Hatsukami D. Effects of abstinence from tobacco: a critical review. In: Kozlowski LT, Annis HM, Cappell HD, et al. Research Advances in Alcohol and Drug Problems. New York: Plenum Publishing; 1990:317–398.
  109. Spitzer RL, Williams JW. Structured Clinical Interview for DSM-III (SCID). New York: Biometrics Research Department, New York State Psychiatric Institute; 1987.
  110. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York: Oxford University Press; 1990.
  111. Jamison KR. Mood disorders and patterns of creativity in British writers and artists. Psychiatry. 1989;52(2): 125–134.
  112. Reuter P, MacCoun R, Murphy P. Money From Crime: A Study of the Economics of Drug Dealing in Washington, DC. Santa Monica: Rand Corporation; June 1990.
  113. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 1988;319(20): 1318–1330. CrossRef
  114. Rose JE, Behm F. Refined cigarette smoke as a method for reducing nicotine intake. Pharmacol Biochem Behav. 1987;28:305–310. CrossRef
  115. Goldfarb TL, Jarvik ME, Glick SD. Cigarette nicotine content as a determinant of human smoking behavior. Psychopharmacology (Berl). 1970;17:89–93. CrossRef

z-ref: xdpgnib3

Jarvik , et al. (1992), Nicotine: Medication or Scourge?, http://link.springer.com/chapter/10.1007/978-1-4613-9194-4_32 accessed: 2014-02-17
research/documents/xdpgnib3.txt · Last modified: 2014/03/29 16:56 by rainman